NCT06609460

Study of CD388 for the Prevention of Influenza in Subjects Not at Risk for Influenza Complications

CompletedPHASE2INTERVENTIONAL

Trial Details

Start: 2024-09-20Est. Completion: 2025-10-09

Enrollment target: 5,071 participants

Locations

Pinnacle Research Group, LLC, Anniston, Alabama, United States
Cullman Clinical Trials, Cullman, Alabama, United States
Fiel Family and Sports Medicine/CCT Research, Tempe, Arizona, United States
Del Sol Research Management, LLC, Tucson, Arizona, United States
Baptist Health Center for Clinical Research, Little Rock, Arkansas, United States
Velocity Clinical Research - Huntington Park, Huntington Park, California, United States
Velocity Clinical Research - San Diego, La Mesa, California, United States
Catalina Research Institute, LLC, Montclair, California, United States
Profound Research LLC, Oceanside, California, United States
Acclaim Clinical Research, San Diego, California, United States
Lynn Institute of the Rockies, Colorado Springs, Colorado, United States
Critical Care, Pulmonary & Sleep Associates, PLLP/CCT Research, Lakewood, Colorado, United States
Alliance for Multispecialty Research, LLC, Fort Myers, Florida, United States
Nature Coast Clinical Research, Inverness, Florida, United States
Health Awareness, LLC, Jupiter, Florida, United States

EBVHSVVZVHPVCMV

Background: * Infections caused by viruses are common causes of illnesses: the common cold, many ear infections, sore t…

Bethesda, United States

Influenza With PneumoniaPulmonary Aspergillosis

A prospective multi-center observational study to assess the incidence of influenza-associated pulmonary aspergillosis (…

Bruges, BelgiumCompleted May 18, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.